Sclerosing cholangitis associated with Wegener's granulomatosis [4]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 11, 2006, Pages 1765-1766

  Yüksel, Ilhami ^a   Dag̀li, Ülkü ^a   Ataseven, Hilmi ^a   Şahin, Burhan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISOLONE; STEROID;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INFLAMMATORY INFILTRATE; LETTER; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; STENT; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 33748762737     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04431.x     Document Type: Letter

References (7)

1. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulamatosis: an analysis of 158 patients. Ann. Int. Med. 1992; 116: 488-98.
2. Bailey M, Chapin W, Licht H, Reynolds JC. The effects of vasculitis on the gastrointestinal tract and liver. Gastroenterol. Clin. North Am. 1998; 27: 747-82.
3. Haworth SJ, Pusey CD. Severe intestinal involvement in Wegener's granulomatosis. Gut 1984; 25: 1296-300.
4. Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitis. Rheum. Dis. Clin. North Am. 1995; 21: 987-1011.
5. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol. 1989; 76: 30-3.
6. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (cANCA) testing in the diagnosis of Wegener's granulomatosis. Ann. Intern. Med. 1995; 123: 925-32.
7. Schnabel A, Csemok E, Schultz H et al. Bactericidal permeability increasing protein (BPI-ANCA) marked chronic inflammatory bowel diseases and hepatobiliary diseases. Med. Klin. (Munich) 1997; 92: 389-93.